Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-Label, Functionality, Reliability, and Performance Study of an Accessorized Pre-filled Syringe With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GREGALE)
Conditions
Interventions
Benralizumab
Locations
23
United States
Research Site
Fountain Valley, California, United States
Research Site
Walnut Creek, California, United States
Research Site
Celebration, Florida, United States
Research Site
Ocala, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Winter Park, Florida, United States
Start Date
April 27, 2015
Primary Completion Date
March 14, 2016
Completion Date
March 14, 2016
Last Updated
May 23, 2018
NCT06979323
NCT07431021
NCT06664619
NCT07383896
NCT07356310
NCT07282886
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions